Kelley Dealhoy

Kelley is a senior advisor in Deloitte’s Mergers & Acquisitions (M&A) practice with a global focus on the Life Sciences & Health Care sector. She has significant experience in the life science sector including pharmaceuticals, consumer, and animal health. With more than 20 years of industry experience, she has had leadership roles in leading multinational pharmaceutical companies in R&D, commercial, and corporate development supporting both emerging and established markets. Most recently, Kelley was the vice president and Global head of Business Development for Novartis Consumer Health business headquartered in NJ, USA. In this role, she and her team were responsible for driving inorganic growth through M&A including bolt on acquisitions with a focus on emerging markets as well as transformational global transactions. Kelley also led the global strategy to stream line the portfolio through divestment. Kelley led, closed, and was responsible for the separation of over 15 businesses involving prescription, OTC, and VMS products during her tenure at Novartis.